
Doctor Johannes Wikstrom
(Sweden)
Membership:
ESC Professional Member
Follow
Contributor content
Presentation
Combination therapy with GalNAc-siRNA drugs targeting both PCSK9 and APOC3 resulted in enhanced lipid lowering in mice
Presentation


